Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Derosa

Showing results (141-150 of 250) with videos related to

Pageof 25
Sort By:
Current Pharmaceutical Design|November 17, 2017
Curcumin: A Natural Pan-HDAC Inhibitor in CancerSara Saffar Soflaei, Amir Abbas Momtazi-Borojeni, Muhammed Majeed, et al.
Endothelium : Journal of Endothelial Cell Research|October 9, 2007
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular diseaseArrigo F G Cicero, Giuseppe Derosa, Marco Manca, et al.
Expert Opinion on Pharmacotherapy|October 16, 2012
A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell functionGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.
Scientific Reports|August 6, 2015
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical TrialGiuseppe Derosa, Amedeo Mugellini, Fabrizio Querci, et al.
Blood Pressure|April 28, 2009
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensivesArrigo Francesco Giuseppe Cicero, Giuseppe Derosa, Angela D'angelo, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 31, 2007
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trialArrigo F G Cicero, Giuseppe Derosa, Marco Manca, et al.
Journal of Clinical Psychopharmacology|February 15, 2021
Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive PatientsAlfredo Costa, Angela D'Angelo, Matteo Cotta Ramusino, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
Journal of Clinical Lipidology|January 15, 2013
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat loadGiuseppe Derosa, Arrigo F G Cicero, Elena Fogari, et al.
Inflammation|September 11, 2013
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Pageof 25

Showing results (141-150 of 250) with videos related to

Sort By:
Pageof 25
Current Pharmaceutical Design|November 17, 2017
Curcumin: A Natural Pan-HDAC Inhibitor in CancerSara Saffar Soflaei, Amir Abbas Momtazi-Borojeni, Muhammed Majeed, et al.
Endothelium : Journal of Endothelial Cell Research|October 9, 2007
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular diseaseArrigo F G Cicero, Giuseppe Derosa, Marco Manca, et al.
Expert Opinion on Pharmacotherapy|October 16, 2012
A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell functionGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.
Scientific Reports|August 6, 2015
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical TrialGiuseppe Derosa, Amedeo Mugellini, Fabrizio Querci, et al.
Blood Pressure|April 28, 2009
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensivesArrigo Francesco Giuseppe Cicero, Giuseppe Derosa, Angela D'angelo, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 31, 2007
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trialArrigo F G Cicero, Giuseppe Derosa, Marco Manca, et al.
Journal of Clinical Psychopharmacology|February 15, 2021
Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive PatientsAlfredo Costa, Angela D'Angelo, Matteo Cotta Ramusino, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
Journal of Clinical Lipidology|January 15, 2013
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat loadGiuseppe Derosa, Arrigo F G Cicero, Elena Fogari, et al.
Inflammation|September 11, 2013
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patientsGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Pageof 25